2022 annual financial data
AbCellera Biologics 2022 Operating margin
AbCellera Biologics 2022 operating margin with verified reported values.
Direct answer
Operating margin was 44.6%.
Operating income was 216,511,000 USD and net income was 158,519,000 USD.
Operating cash flow was 277,360,000 USD.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 485,424,000 USD
- Operating income
- 216,511,000 USD
- Net income
- 158,519,000 USD
- Operating cash flow
- 277,360,000 USD